Clusterin as an Alzheimer biomarker

Archives of Neurology

Volumn 68, Issue 11, 2011, Pages 1459-1460

  Hardy, John ^a   Guerreiro, Rita ^a   Lovestone, Simon ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b King's College London ^*  (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PROTEIN; APOLIPOPROTEIN E; BIOLOGICAL MARKER; CLUSTERIN;

ALZHEIMER DISEASE; APOE GENE; CLU GENE; DISEASE ASSOCIATION; DISEASE MARKER; ENTORHINAL CORTEX; GENE; HUMAN; NONHUMAN; NONSENSE MUTATION; NOTE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR;

ALZHEIMER DISEASE; CLUSTERIN; FEMALE; HUMANS; MALE;

EID: 81355154156     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneurol.2011.1000     Document Type: Note

References (11)

1. May PC, Lampert-Etchells M, Johnson SA, Poirier J, Masters JN, Finch CE. Dynamics of gene expression for a hippocampal glycoprotein elevated in Alzheimer's disease and in response to experimental lesions in rat. Neuron. 1990; 5(6):831-839.
2. Poirier J, Hess M, May PC, Finch CE. Cloning of hippocampal poly(A) RNA sequences that increase after entorhinal cortex lesion in adult rat. Brain Res Mol Brain Res. 1991;9(3):191-195.
3. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 1993;261(5123):921-923. (Pubitemid 23275809)
4. Harold D, Abraham R, Hollingworth P, et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet. 2009;41(10):1088-1093.
5. Chartier-Harlin MC, Parfitt M, Legrain S, et al. Apolipoprotein E, epsilon 4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region. Hum Mol Genet. 1994;3(4):569-574.
6. Guerreiro RJ, Beck J, Gibbs JR, et al. Genetic variability in CLU and its association with Alzheimer's disease. PLoS One. 2010;5(3):e9510.
7. Thambisetty M, Simmons A, Velayudhan L, et al. Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease. Arch Gen Psychiatry. 2010;67(7):739-748.
8. Schrijvers EM, Koudstaal PJ, Hofman A, Breteler MM. Plasma clusterin and the risk of Alzheimer disease. JAMA. 2011;305(13):1322-1326.
9. Tycko B, Feng L, Nguyen L, et al. Polymorphisms in the human apolipoprotein- J/clusterin gene: ethnic variation and distribution in Alzheimer's disease. Hum Genet. 1996;98(4):430-436. (Pubitemid 26336167)
10. DeMattos RB, Cirrito JR, Parsadanian M, et al. ApoE and clusterin cooperatively suppress Abeta levels and deposition: evidence that ApoE regulates extracellular Abeta metabolism in vivo. Neuron. 2004;41(2):193-202. (Pubitemid 38125181)
11. Thambisetty M, Tripaldi R, Riddoch-Contreras J, et al. Proteome-based plasma markers of brain amyloid-β deposition in non-demented older individuals. J Alzheimers Dis. 2010;22(4):1099-1109.